Yolla El‐Dakdouki
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Genetic factors in colorectal cancer, Viral-associated cancers and disorders
Most-Cited Works
- → Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine(2017)140 cited
- → Sequence analyses of relapsed or refractory diffuse large B‐cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH‐EP1 study(2023)4 cited
- → Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B‐cell lymphoma: Results of LNH‐EP1 study(2021)2 cited
- → Abstract CT141: Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial)(2018)
- → Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and <i>GNA3</i> Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study(2022)